Literature DB >> 29506080

Which supplements can I recommend to my osteoarthritis patients?

Xiaoqian Liu1,2, Jillian Eyles1,2,3, Andrew J McLachlan4, Ali Mobasheri5,6.   

Abstract

OA is a chronic and disabling joint disease with limited evidence-based pharmacological treatment options available that improve outcomes for patients safely. Faced with few effective pharmacological treatments, the use has grown of dietary supplements and complementary medicines for symptomatic relief among people living with OA. The aim of this review is to provide a summary of existing evidence and recommendations supporting the use of supplements for OA. Systematic reviews and randomized controlled trials investigating oral supplements for treating OA were identified. Limited research evidence supports recommendations for the oral use of Boswellia serrata extract and Pycnogenol, curcumin and methylsulfonylmethane in people with OA despite the poor quality of the available studies. Few studies adequately reported possible adverse effects related to supplementation, although the products were generally recognized as safe. Further high quality trials are needed to improve the strength of evidence to support this recommendation and better guide optimal treatment of people living with OA.

Entities:  

Mesh:

Year:  2018        PMID: 29506080     DOI: 10.1093/rheumatology/key005

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  6 in total

Review 1.  Natural Products for Promoting Joint Health and Managing Osteoarthritis.

Authors:  Yves Henrotin; Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2018-09-19       Impact factor: 4.592

2.  Efficacy and safety of a supplement combination for hand osteoarthritis pain: protocol for an internet-based randomised placebo-controlled trial (The RADIANT study).

Authors:  Xiaoqian Liu; Sarah Robbins; Jillian Eyles; Tatyana Fedorova; Sonika Virk; Leticia A Deveza; Andrew McLachlan; David Hunter
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

Review 3.  A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?

Authors:  Ursule Kalvaityte; Ilona Uzieliene; Christina E Larder; Michèle M Iskandar; Ali Mobasheri; Armaghan Mahmoudian; Stan Kubow; Paulo Cesar Hamdan; Cyro Scala de Almeida; Lacey J Favazzo; Luc J C van Loon; Pieter J Emans; Pérola G Plapler; Michael J Zuscik
Journal:  Curr Rheumatol Rep       Date:  2021-10-30       Impact factor: 4.686

Review 4.  Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis.

Authors:  Vidhu Sethi; Manohar Garg; Maxime Herve; Ali Mobasheri
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-22       Impact factor: 3.625

Review 5.  Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities.

Authors:  Reza Mohammadinejad; Milad Ashrafizadeh; Abbas Pardakhty; Ilona Uzieliene; Jaroslav Denkovskij; Eiva Bernotiene; Lauriane Janssen; Gabriela S Lorite; Simo Saarakkala; Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2020-04-04       Impact factor: 4.592

6.  Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose-Effect Relationships in an Experimental In Vitro Model of Osteoarthritis.

Authors:  Angela D'Ascola; Natasha Irrera; Roberta Ettari; Alessandra Bitto; Giovanni Pallio; Federica Mannino; Marco Atteritano; Giuseppe M Campo; Letteria Minutoli; Vincenzo Arcoraci; Violetta Squadrito; Giacomo Picciolo; Francesco Squadrito; Domenica Altavilla
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.